202 related articles for article (PubMed ID: 27588182)
1. DNA methylation and leukemia susceptibility in China: Evidence from an updated meta-analysis.
Jiang D; Li Y; Hong Q; Shen Y; Xu C; Xu Y; Zhu H; Dai D; Ouyang G; Duan S
Mol Clin Oncol; 2016 Sep; 5(3):193-207. PubMed ID: 27588182
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysis.
Jiang D; Hong Q; Shen Y; Xu Y; Zhu H; Li Y; Xu C; Ouyang G; Duan S
PLoS One; 2014; 9(5):e96822. PubMed ID: 24810788
[TBL] [Abstract][Full Text] [Related]
3. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA).
Cao Z; Wei L; Zhu W; Yao X
Medicine (Baltimore); 2018 Mar; 97(12):e0182. PubMed ID: 29561434
[TBL] [Abstract][Full Text] [Related]
5. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
6. CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis.
Zhou Y; Wang XB; Qiu XP; Shuai Zhang ; Wang C; Zheng F
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):529-541. PubMed ID: 30143452
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia.
Cechova H; Lassuthova P; Novakova L; Belickova M; Stemberkova R; Jencik J; Stankova M; Hrabakova P; Pegova K; Zizkova H; Cermak J
Neoplasma; 2012; 59(2):168-74. PubMed ID: 22248274
[TBL] [Abstract][Full Text] [Related]
8. Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders.
Kawamata N; Inagaki N; Mizumura S; Sugimoto KJ; Sakajiri S; Ohyanagi-Hara M; Oshimi K
Eur J Haematol; 2005 May; 74(5):424-9. PubMed ID: 15813917
[TBL] [Abstract][Full Text] [Related]
9.
Zhong J; Chen X; Ye H; Wu N; Chen X; Duan S
Exp Ther Med; 2017 Dec; 14(6):6093-6098. PubMed ID: 29285163
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic effects of
Xia L; Zhang W; Gao L
Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782
[No Abstract] [Full Text] [Related]
11. The association between methylated CDKN2A and cervical carcinogenesis, and its diagnostic value in cervical cancer: a meta-analysis.
Li J; Zhou C; Zhou H; Bao T; Gao T; Jiang X; Ye M
Ther Clin Risk Manag; 2016; 12():1249-60. PubMed ID: 27574435
[TBL] [Abstract][Full Text] [Related]
12. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
13. [Methylation of the genes in the 9P21 region in children with acute myeloid leukemia].
Zhang L; Ruan M; Liu XM; Zhang JY; Guo Y; Yang WY; Liu F; Liu TF; Wang SC; Chen XJ; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):6-10. PubMed ID: 25616284
[TBL] [Abstract][Full Text] [Related]
14. Meta-analyses of methylation markers for prostate cancer.
Jiang D; Shen Y; Dai D; Xu Y; Xu C; Zhu H; Huang T; Duan S
Tumour Biol; 2014 Oct; 35(10):10449-55. PubMed ID: 25053593
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis.
Zhang W; Kuang P; Liu T
Ann Med; 2019 Feb; 51(1):28-40. PubMed ID: 30592434
[TBL] [Abstract][Full Text] [Related]
16. CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia.
Jang W; Park J; Kwon A; Choi H; Kim J; Lee GD; Han E; Jekarl DW; Chae H; Han K; Yoon JH; Lee S; Chung NG; Cho B; Kim M; Kim Y
Exp Mol Med; 2019 Jan; 51(1):1-15. PubMed ID: 30635552
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas.
Arya AK; Bhadada SK; Singh P; Sachdeva N; Saikia UN; Dahiya D; Behera A; Bhansali A; Rao SD
Sci Rep; 2017 Jun; 7(1):3123. PubMed ID: 28600574
[TBL] [Abstract][Full Text] [Related]
19. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
20. Methylation of
Hu Q; Chen X; Liu S; Wen R; Yuan X; Xu D; Liu G; Wen F
Oncol Lett; 2017 Apr; 13(4):2115-2120. PubMed ID: 28454370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]